26.05 USD
▼-0.80-2.98%
盘后 25.35 0.00%
2026-09-15
市值
$1.86B
市盈率
—
EPS
-2.01
股息率
—
52 周区间
15.49 – 31.34
成交量
552.15K
Beta
1.19
目标价
41.75
52W 低 15.4952W 高 31.34
价格走势
公司简介
Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases. The company’s platforms include Azymetric multispecific antibody platform; Drug Conjugate platform that includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT platform, which consists of a set of modifications to the Fc region of antibodies; and ProTECT, a tumor-specific immune co-stimulation platform. Its lead pr...